A Phellinus baumii extract reduces obesity in high-fat diet-fed mice and absorption of triglyceride in lipid-loaded mice

Journal of Medicinal Food

Volumn 14, Issue 3, 2011, Pages 209-218

  Noh, Jung Ran ^a,b   Lee, In Kyoung ^c   Ly, Sun Yung ^b   Yang, Keum Jin ^a   Gang, Gil Tae ^a   Kim, Yong Hoon ^a   Hwang, Jung Hwan ^a   Yun, Bong Sik ^c   Lee, Chul Ho ^a  

^a Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

^b Chungnam National University   (South Korea)

^c Chonbuk National University   (South Korea)

Author keywords

anti obesity; hepatic lipid; Phellinus baumii; triglyceride absorption

Indexed keywords

ADIPOCYTOKINE; ANTILIPEMIC AGENT; CHOLESTEROL; DAVALLIALACTONE; FATTY ACID SYNTHASE; HYPHOLOMINE B; INTERFUNGIN A; LEPTIN; LIPID; MESSENGER RNA; PHELLINUS BAUMII EXTRACT; PLANT EXTRACT; PLANT MEDICINAL PRODUCT; TETRAHYDROLIPSTATIN; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ADIPOCYTE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY FAT; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVITY; EPIDIDYMIS FAT; FRUITING BODY; GENE EXPRESSION; INTESTINE ABSORPTION; LIPID ABSORPTION; LIPID BLOOD LEVEL; LIPID DIET; LIPID LIVER LEVEL; LIPID STORAGE; LIPOGENESIS; MALE; MOUSE; MUSHROOM; NONHUMAN; OBESITY; PHELLINUS BAUMII; PRIORITY JOURNAL; PROADIPOCYTE; SCORING SYSTEM; WEIGHT REDUCTION;

ADIPOCYTES; ADIPOSE TISSUE; ANIMALS; ANTI-OBESITY AGENTS; BASIDIOMYCOTA; BIOLOGICAL PRODUCTS; DIETARY FATS; EPIDIDYMIS; FATTY ACID SYNTHETASE COMPLEX; INTESTINAL ABSORPTION; LACTONES; LIPID METABOLISM; LIVER; MALE; MICE; MICE, INBRED C57BL; OBESITY; PHYTOTHERAPY; RANDOM ALLOCATION; RNA, MESSENGER; TRIGLYCERIDES; WEIGHT GAIN;

INONOTUS BAUMII; MUS;

EID: 79951965457     PISSN: 1096620X     EISSN: None     Source Type: Journal    
DOI: 10.1089/jmf.2010.1152     Document Type: Article

References (31)

1. Stulc T, Cecka R: [Lipid-lowering treatment in metabolic syndrome]. Vnitr Lek 2009;55:626-630.
2. Pagotto U, Vanuzzo D, Vicennati V, Pasquali R: [Pharmacological therapy of obesity]. G Ital Cardiol (Rome) 2008;9(4 Suppl 1):83S-93S.
3. Chapman MJ: Fibrates in 2003: therapeutic action in atherogenic dyslipidaemia and future perspectives. Atherosclerosis 2003;171:1-13.
4. Padwal RS, Majumdar SR: Drug treatments for obesity: orlistat, sibutramine, and rimonabant. Lancet 2007;369:71-77. (Pubitemid 46027230)
5. Bray GA: Drug treatment of obesity. Rev Endocr Metab Disord 2001;2:403-418.
6. Ruan Z, Su J, Dai HC, Wu MC: Characterization and immunomodulating activities of polysaccharide from Lentinus edodes. Int Immunopharmacol 2005;5:811-820.
7. Dai YC, Xu MQ: Studies on the medicinal polypore, Phellinus baumii, and its kin, P. linteus. Mycotaxon 1998;67:191-200.
8. Bae JS, Jang KH, Yim H, Park SC, Jin HK: Inhibitory effects of polysaccharides isolated from Phellinus gilvus on benzo(a)pyrene-induced forestomach carcinogenesis in mice. World J Gastroenterol 2005;11:577-579. (Pubitemid 40185598)
9. Kim BC, Jeon WK, Hong HY, Jeon KB, Hahn JH, Kim YM, Numazawa S, Yosida T, Park EH, Lim CJ: The anti-inflammatory activity of Phellinus linteus (Berk. & M.A. Curt.) is mediated through the PKCdelta=Nrf2=ARE signaling to up-regulation of heme oxygenase-1. J Ethnopharmacol 2007;113:240-247. (Pubitemid 47239247)
10. Ye SF, Hou ZQ, Zhang QQ: Protective effects of Phellinus linteus extract against iron overload-mediated oxidative stress in cultured rat hepatocytes. Phytother Res 2007;21:948-953.
11. Zhu T, Guo J, Collins L, Kelly J, Xiao ZJ, Kim SH, Chen CY: Phellinus linteus activates different pathways to induce apoptosis in prostate cancer cells. Br J Cancer 2007;96:583-590.
12. Chang ZQ, Oh BC, Lee SP, Rhee MH, Park SC: Comparative immunomodulating activities of polysaccharides isolated from Phellinus spp. on cell-mediated immunity. Phytother Res 2008;22:1396-1399.
13. Cho EJ, Hwang HJ, Kim SW, Oh JY, Baek YM, Choi JW, Bae SH, Yun JW: Hypoglycemic effects of exopolysaccharides produced by mycelial cultures of two different mushrooms Tremella fuciformis and Phellinus baumii in ob=ob mice. Appl Microbiol Biotechnol 2007;75:1257-1265. (Pubitemid 46976685)
14. Shin TY, Shin HY, Kim SH, Kim DK, Chae BS, Oh CH, Cho MG, Oh SH, Kim JH, Lee TK, Park JS, Kim SY: Phellinus baumii inhibits immediate-type allergic reactions. Nat Prod Sci 2006;12:232-236.
15. Shon MY, Kim TH, Sung NJ: Antioxidants and free radical scavenging activity of Phellinus baumii (Phellinus of Hymenochaetaceae) extracts. Food Chem 2003;82:593-597.
16. Lee IK, Yun BS: Highly oxygenated and unsaturated metabolites providing a diversity of hispidin class antioxidants in the medicinal mushrooms Inonotus and Phellinus. Bioorg Med Chem 2007;15:3309-3314.
17. Jung JY, Lee IK, Seok SJ, Lee HJ, Kim YH, Yun BS: Anti-oxidant polyphenols from the mycelial culture of the medicinal fungi Inonotus xeranticus and Phellinus linteus. J Appl Microbiol 2008;104:1824-1832.
18. Bligh EG, Dyer WJ: A rapid method of total lipid extraction and purification. Can J Biochem Physiol 1959;37:911-917.
19. Hulcher FH, Oleson WH: Simplified spectrophotometric assay for microsomal 3-hydroxy-3-methylglutaryl Co A reductase by measurement of coenzyme A. J Lipid Res 1974;14:625-632.
20. Nepokroeff CM, Lakshmanan MR, Porter JW: Fatty acid synthase from rat liver. Methods Enzymol 1975;35:37-44.
21. Markwell MAK, McGroarty EJ, Bieber LL, Tolbert NE: The subcellular distribution of carnitine acyltransferases in mammalian liver and kidney. J Biol Chem 1973;248:3426-3432.
22. Wilkening D, Mundy BP: A cyclopentane, cyclopentene and cyclopentanone annulations methodology. Synth Commun 1984;14:227.
23. Mizuarai S, Miki S, Araki H, Takahashi K, Kotani H: Identification of dicarboxylate carrier Slc25a10 as malate transporter in de novo fatty acid synthesis. J Biol Chem 2005;280:32434-32441. (Pubitemid 41361855)
24. Zhi J, Melia AT, Guerciolini R, Chung J, Kinberg J, Hauptman JB, Patel IH: Retrospective population-based analysis of the dose-response (fecal fat excretion) relationship of orlistat in normal and obese volunteers. Clin Pharmacol Ther 1994;56:82-85. (Pubitemid 24251568)
25. Considine RV, Subha MK, Heiman ML, Kriauciunas A, Stephens TW, Nyce M, Ohannesian JP, Marco CC, McKee LJ, Bauer TL, Caro JF: Serum immunoreactive- leptin concentrations in normal weight and obese humans. N Engl J Med 1996;334:292-295. (Pubitemid 26033933)
26. Hara T, Fujiwara H, Shoji T, Mimura T, Nakao H, Fujimoto S: Decreased plasma adiponectin levels in young obese males. J Atheroscler Thromb 2003;10:234-238.
27. Browing JD, Horton JD: Molecular mediators of hepatic steatosis and liver injury. J Clin Invest 2004;114:147-152.
28. nd, Gorelick F: Development and physiological regulation of intestinal lipid absorption. II. Dietary lipid absorption, complex lipid synthesis, and the intracellular packaging and secretion of chylomicrons. Am J Physiol Gastrointest Liver Physiol 2007;293:G645-G650.
29. Ninomiya K, Matsuda H, Shimoda H, Nishida N, Kasajima N, Yoshino T, Morikawa T, Yoshikawa M: Carnosic acid, a new class of lipid absorption inhibitor from sage. Bioorg Med Chem Lett 2004;14:1943-1946. (Pubitemid 38410869)
30. Kim SD, Lee IK, Lee WM, Cho JY, Park HJ, Oh JW, Park SC, Kim SK, Kwak YS, Yun BS, Rhee MH: The mechanism of anti-platelet activity of davallialactone: involvement of intracellular calcium ions, extracellular signal-regulated kinase 2 and p38 mitogen-activated protein kinase. Eur J Pharmacol 2008;584:361-367.
31. Lee YG, Lee WM, Kim JY, Lee JY, Lee IK, Yun BS, Rhee MH, Cho JY: Src kinase-targeted anti-inflammatory activity of davallialactone from Inonotus xeranticus in lipopolysaccharide-activated RAW264.7 cells. Br J Pharmacol 2008;154:852-863. (Pubitemid 351821587)